NCT05614518View on ClinicalTrials.gov

Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTc⁃MDP-BS±SPECT

PHASE3CompletedINTERVENTIONAL

Enrollment

280

Participants

Timeline

Start Date

March 29, 2021

Primary Completion Date

June 2, 2022

Study Completion Date

June 2, 2022

Conditions

Bone Metastases

Interventions

DRUG

Sodium Fluoride F-18 Injection

Each subject was given 5-10 mCi intravenously. Images were collected 90-120 min after injection.

DRUG

Technetium[99mTc] Methylenediphosphonate Injection

Each subject was given 10-25 mCi intravenously. Images were collected 3-6 hours after injection.

Trial Locations (1)

Unknown

Chinese Academy of Medical Sciences Peking Union Medical College Hospital, Beijing

All Listed Sponsors

lead

HTA Co., Ltd.

INDUSTRY

NCT05614518 - Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTc⁃MDP-BS±SPECT | Biotech Hunter | Biotech Hunter